Michelle Myers

Michelle has 10 years of experience in the biotechnology industry in addition to an array of scientific and collaborative experiences spanning the UK, US and Australia. Prior to joining NuCana, Michelle was a Medical Scientific Liaison with Roche, specializing in cancer immunotherapy and breast cancer. As VP of Medical & Scientific Affairs, Michelle applies her strong academic background together with her extensive therapeutic area knowledge to advance the clinical development of NuCana’s pipeline. Michelle has over 20 peer-reviewed publications and continues to maintain strong academic and industry collaborations. Michelle received a PhD in reproductive biology from the University of Edinburgh and first-class BSc (Hons) from Monash University in Melbourne Australia.